STEPHANIE KAPSIMALLIS: Open Payments
NPI 1508202813 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,284 in 50 payments from 29 companies in 2025. Trend: 2023 $585 · 2024 $714 · 2025 $1,284
Food & beverage: $1,189Education: $95
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $177 |
| AstraZeneca Pharmaceuticals LP | 4 | $100 |
| SEAGEN INC. | 1 | $95 |
| ARRAY BIOPHARMA INC | 7 | $95 |
| Kite Pharma, Inc. | 2 | $87 |
| Genentech USA, Inc. | 3 | $74 |
| TerSera Therapeutics LLC | 2 | $61 |
| Caris MPI, Inc. | 2 | $56 |
| SOBI, INC | 2 | $49 |
| Merck Sharp & Dohme LLC | 2 | $46 |
Products named: BREYANZI, Yescarta, TAGRISSO, MI CANCER SEEK, LORBRENA, Polivy, Vonjo, KEYTRUDA.
Industry payments across CA — which companies pay providers there.
